OBJECTIVE:
The purpose of this study was to determine whether the use of ultrasonic shears in the harvest of microvascular free-flaps reduces operative time while maintaining acceptable outcomes. METHOD: Prospective non-randomized trial of the use of ultrasonic shears in the harvest of fibula and anterolateral thigh microvascular free-flaps used in head and neck reconstruction from October 2005 through December 2009 at a tertiary referral center. RESULTS: There were 108 fibula and anterolateral thigh free-flaps enrolled in the study. Ultrasonic shears were used in 53 fibula and 26 anterolateral thigh free-flaps while the traditional clamp-cut-tie method of harvesting was used in 16 fibula and 13 anterolateral thigh free-flaps. The average time of fibula free-flap harvest with ultrasonic shears was significantly reduced at 48.2 ϩ/-4.3 minutes compared to controls at 62.7 ϩ/-9.0 minutes (p0.05). CONCLUSION: The use of ultrasonic shears for the harvest of microvascular free-flaps for head and neck reconstruction significantly increases the efficiency by reducing operative time without an increased risk of complications. The reduced operating room time leads to significantly reduced costs.
General Otolaryngology
Celecoxib and Pregabalin for Tonsillectomy Pain Patrick Murphy, MD, FRCSC (presenter) OBJECTIVE: To test the hypothesis that the combination of celecoxib and pregabalin does not increase the incidence of secondary post-tonsillectomy bleeding by more than 5% compared to the use of opioids alone. METHOD: Based on a sample size calculation, a total of 305 charts of patients undergoing tonsillectomy using the electrocautery technique were retrospectively reviewed. Primary and secondary post-tonsillectomy bleeding was identified as was presentation to the emergency department for pain or dehydration. Non-inferiority testing was used with an equivalence margin of 5%. RESULTS: 176 patients received opioids while 129 received the new routine. The secondary bleeding rate was 9.1% for the New Routine and 13.7% for opioids. The 95% confidence interval comparing the bleeding rate of the New Routine to Opioids was -10.4% to ϩ1.4% (pϭ0.004). Significantly more patients receiving Opioids presented to the emergency department for pain or dehydration (8.8% vs 0.8%, PϽ0.002). CONCLUSION: Although overall secondary bleeding rates were higher than expected, there is no evidence that the combination of celecoxib, pregabalin and tramadol increases in the incidence of post-operative bleeding by more than 5%. Interestingly, the combination of celecoxib and pregabalin resulted in a lower bleeding rate. All patients also used a topical NSAID mouth wash (benzydamine) post-op, which may have contributed to the high bleeding rates. Future prospective studies are required.
Comparing Sleep Endoscopy to Mallampati and Mü ller Maneuver
Ismet Emre, MD (presenter); Senol Civelek, MD; Muge Ozcelik, MD; Suat Turgut, MD; Birsen Eksioglu Karaci, MD OBJECTIVE: Our main objective was to evaluate if sleep endoscopy findings were in correlation with the Müller maneuver findings in accordance with the site of obstruction and whether the Mallampati score is an actual indicator of the level of obstruction as seen on sleep endoscopy. An additional result was obtained in the comparison of the Mallampati score with the Müller maneuver.
METHOD:
The study was a prospective randomized clinical trial. The study was carried out in 9 months. 40 Patients with OSAS were included in the study. All patients were examined for the Mallampati score, then underwent flexible nasoendoscopy for the Müller maneuver and finally were sedated in the operating theater where sleep endoscopy was performed. The T-test was used to determine the average of basic data-independent variables (Age, EUS, BMI, AHI, and Neck Circumference Measurement). The McNemar test, used to assess the results of dependent groups, was used to compare the results of the examinations. The compatibility of the findings of the Mallampati test and sleep endoscopy was assessed via the kappa test, and for values lower then 0.50 it was accepted that the two methods were not similar in terms of their distinctive marks.
P45
Oral Presentations ORALS RESULTS: Endoscopy and Müller Maneuver were compared at the uvulopalatal level, the lateral pharyngeal level, the tongue base and at the laryngeal level in terms of their effectiveness in determining obstruction. There was a significant difference in favor of endoscopy with 95% confidence (pϽ0.05). Therefore it can be claimed that sleep endoscopy is better at determining obstructive pathology. Sleep endoscopy and MMS were compared for their success in determining tongue root obstruction by using the kappa test. There was a significant difference between MMS and sleep endoscopy (kappaϭ0.2) in regards to their identifying characteristics for tongue root obstructions. The false negative rate was 0.5 and the false positive rate was 0.2 for MMS. It can be concluded that in terms of identifying obstruction at the tongue base, between the two tests, sleep endoscopy proves more useful. CONCLUSION: Although the Müller maneuver is an effective evaluation technique for sites of obstruction in OSAS, sleep endoscopy is a more reliable technique in that it is done in a more similar state to which obstruction occurs (i.e., sleep). The MMS has very little to offer when diagnosing tongue base obstruction when compared to sleep endoscopy. We believe that sleep endoscopy should be mandatory for any patient before undergoing surgery for OSAS.
Demographics and Efficacy of Head and Neck Cancer Screening
Payam Entezami (presenter); Anna Chernin; Jeremy Taylor, PhD; Norman Hogikyan, MD OBJECTIVE: This study was designed to 1) describe the demographics and 2) determine the efficacy of a head and neck cancer screening program in order to optimize future programs. METHOD: After IRB approval, we conducted a retrospective cohort study to review a single institution's 14-year experience (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) ) conducting a free annual head and neck cancer screening clinic. Available demographic and clinical data, as well as clinical outcomes were analyzed for all participants (nϭ761). The primary outcome was the presence of a finding suspicious for head and neck cancer on screening evaluation. RESULTS: Five percent of participants had findings suspicious for head and neck cancer on screening evaluation, and malignant or pre-malignant lesions were confirmed in one percent of participants. Lack of insurance (pϭ.05), tobacco use (pϽ.001), male gender (pϭ.03), separated marital status (pϭ.03), and younger age (pϭ.04) were the significant demographic predictors of a lesion suspicious for malignancy. Patients complaining of a neck mass (pϽ.001) or oral pain (pϽ.001) were significantly more likely to have findings suspicious of malignancy. A high percentage (40%) was diagnosed with benign otolaryngologic pathologies on screening evaluation. CONCLUSION: A minority of patients presenting to a head and neck cancer screening clinic will have a suspicious lesion identified. Given these findings, in order to achieve maximal potential benefit, future head and neck cancer screening clinics should target patients with identifiable risk factors and take full advantage of opportunities for education and prevention.
